BIOMAT Database Logo BIOMAT Database Logo

Synthesis of some 3-(arylalkylthio)-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazole derivatives and their anticonvulsant activity. 2004

Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Marmara University, Tibbiye Cad. No. 49, Haydarpasa, 34668 Istanbul, Turkey. ikucukguzel@marmara.edu.tr

A series of novel 3-[[(substituted phenyl)methyl]thio]-4-alkyl/aryl-5-(4-aminophenyl)-4H-1,2,4-triazoles 11-20 and several related Schiff's bases, 3-[[(substituted phenyl)-methyl]thio]-4-alkyl/aryl-5-[[[(substituted phenyl/5-nitro-2-furyl)methylene]amino]-phenyl]-4H-1,2,4-triazoles 21-31 were synthesized for evaluation of their biological properties. Structures of the synthesized compounds were confirmed by the use of their spectral data besides elemental analysis. All compounds were evaluated for their anticonvulsant activity by maximal electroshock (MES), subcutaneous pentylenetetrazole (scPTZ) and neurotoxicity (NT) screens. A number of triazole derivatives, exhibited protection after intraperitoneal administration at the dose of 100 and 300 mg/kg in one or both models employed. Compounds 12, 13 and 14 were subjected to oral MES screening in rats at 30 mg/kg and were observed to protect 50% of the animals employed in the experiment. Antimicrobial and antituberculosis activity of these compounds 11-31 were also screened. Some of the tested compounds showed marginal activity against M. tuberculosis H37 Rv.

UI MeSH Term Description Entries
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D010433 Pentylenetetrazole A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility. Leptazole,Pentamethylenetetrazole,Pentetrazole,Cardiazol,Corasol,Corazol,Corazole,Korazol,Korazole,Metrazol,Metrazole,Pentazol,Pentylenetetrazol
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004597 Electroshock Induction of a stress reaction in experimental subjects by means of an electrical shock; applies to either convulsive or non-convulsive states. Electroconvulsive Shock,Electroconvulsive Shocks,Electroshocks,Shock, Electroconvulsive,Shocks, Electroconvulsive
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
4-alkyl-5-aryl-4H-1,2,4-triazole-3-thiols as hypoglycemic agents.
July 1970, Journal of medicinal chemistry,
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis of some 4-arylidenamino-4H-1,2,4-triazole-3-thiols and their antituberculosis activity.
August 2007, Journal of enzyme inhibition and medicinal chemistry,
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Effect of Linker Elongation on the VGSC Affinity and Anticonvulsant Activity among 4-Alkyl-5-aryl-1,2,4-triazole-3-thione Derivatives.
July 2023, Molecules (Basel, Switzerland),
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis, spectral characterization, and pharmacological screening of some 4-[{1-(aryl)methylidene}-amino]-3-(4-pyridyl)-5-mercapto-4H-1,2,4-triazole derivatives.
April 2010, Journal of pharmacy & bioallied sciences,
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis and Anticonvulsant Activity Evaluation of 3-alkoxy-4-(4-(hexyloxy/heptyloxy)phenyl)-4H-1,2,4 -triazole.
January 2015, Iranian journal of pharmaceutical research : IJPR,
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis of 5-(2-,3- and 4-methoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives exhibiting anti-inflammatory activity.
April 2004, Farmaco (Societa chimica italiana : 1989),
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis of some 3-arylamino-5-aryloxymethyl[1,2,4]triazole derivatives and their antimicrobial activity.
January 1998, Pharmaceutica acta Helvetiae,
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis and hypoglycemic activity of 3-aryl(or pyridyl)-5-alkyl(or aryl)amino-1,3,4-thiadiazoles and some sulfonylurea derivatives of 4H-1,2,4-triazoles.
October 1971, Journal of medicinal chemistry,
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis and anticonvulsant activity of some novel 3-aryl amino/amino-4-aryl-5-imino-Delta2-1,2,4-thiadiazoline.
April 2008, European journal of medicinal chemistry,
Ilkay Küçükgüzel, and S Güniz Küçükgüzel, and Sevim Rollas, and Gülten Otük-Saniş, and Osman Ozdemir, and Ibrahim Bayrak, and Tuncay Altuğ, and James P Stables
Synthesis of 4-Alkyl-4H-1,2,4-triazole Derivatives by Suzuki Cross-coupling Reactions and Their Luminescence Properties.
February 2019, Molecules (Basel, Switzerland),
Copied contents to your clipboard!